Up to USD 150,000.00 CREDIT FACILITIES AGREEMENTFacilities Agreement • February 28th, 2020 • NLS Pharmaceutics Ltd. • Pharmaceutical preparations
Contract Type FiledFebruary 28th, 2020 Company IndustryWHEREAS the Company shall undertake (i) the commercial development of the patents Lauflamide and its enantiomers, the method for the preparation of the same and the therapeutic uses thereof; Phacetoperane for the treatment of attention-deficit hyperactivity disorder; and the use of iron for the treatment of attention deficit hyperactivity disorder; as well as (ii) the securement of the patents for the medicaments Quinoleine, Tryptamine and Aminoquinoaxaline;
Second Amendment Agreement to Assignment and transfer agreementSecond Amendment Agreement • February 28th, 2020 • NLS Pharmaceutics Ltd. • Pharmaceutical preparations
Contract Type FiledFebruary 28th, 2020 Company Industry
convertible Loan AGREEMENTLoan Agreement • February 28th, 2020 • NLS Pharmaceutics Ltd. • Pharmaceutical preparations
Contract Type FiledFebruary 28th, 2020 Company Industry
Amendment Agreement to Assignment and transfer agreementAmendment Agreement • February 28th, 2020 • NLS Pharmaceutics Ltd. • Pharmaceutical preparations
Contract Type FiledFebruary 28th, 2020 Company Industry
Assignment and transfer agreementAssignment and Transfer Agreement • February 28th, 2020 • NLS Pharmaceutics Ltd. • Pharmaceutical preparations
Contract Type FiledFebruary 28th, 2020 Company Industry
License and Development Agreement “Agreement” betweenLicense and Development Agreement • February 28th, 2020 • NLS Pharmaceutics Ltd. • Pharmaceutical preparations
Contract Type FiledFebruary 28th, 2020 Company Industry